Journal article
Assessing the Economic Value of a New Antidepressant
Abstract
Using the method of willingness to pay (WTP). this study assesses the value of a new antidepressant, moclobemide. relative to that of tricyclic antidepressants (TCAs). which have equivalent efficacy but less favourable adverse effect profiles. From a published meta-analysis of controlled clinical trials. we identified 7 adverse effects. the risk of which differed significantly between moclobemide and TCAs. We obtained risk reduction data and …
Authors
O’Brien BJ; Novosel S; Torrance G; Streiner D
Journal
PharmacoEconomics, Vol. 8, No. 1, pp. 34–45
Publisher
Springer Nature
Publication Date
July 1995
DOI
10.2165/00019053-199508010-00006
ISSN
1170-7690